Omics: Advances, Applications, AND TRANSLATION
in Nutrition and Epidemiology- 3rd ANNUAL SYMPOSIUM.
AGENDA - MAY 2017 - BOSTON
This 3'd Annual Sympsoium is designed to foster an open exchange of ideas about diet and health in the United States.
lt is a unique event, bringing together academics and experts in emerging omics technologies and techniques, with an emphasis on recent advances, applications in population-based research, integration with nutrition, and translational applications.
lt is a unique event, bringing together academics and experts in emerging omics technologies and techniques, with an emphasis on recent advances, applications in population-based research, integration with nutrition, and translational applications.
Tuesday, May 30, 2017
9:00–9:15 Overview of program, introduction to systems epidemiology Frank Hu, MD, PhD, Chair, Dpt. Nutrition, Harvard T.H. Chan School of Public Health
9:15–9:45 Novel findings in genomics/metabolomics in the ARIC Study Eric Boerwinkle, PhD, Baylor College of Medicine, Houston
9:45–10:15 The Women’s Genome Health Study (WGHS): Recent progress and opportunities in the genetic epidemiology of aging Daniel Chasman, MD, PhD, Brigham and Women’s Hospital
10:15–10:45 Precision nutrition for obesity management based on omics J Alfredo Martínez, MD PhD, Universidad de Navarra (Pamplona, Spain)
10:45–11:15 Coffee break
11:15–11:45 Genetic variation on T2D traits James B Meigs, MD, PhD, Massachusetts General Hospital
11:45–12:15 Metabolomics and other omics of diabetes Thomas J Wang, PhD, Vanderbilt University Medical Center
12:15–12:45 Genes, Lifestyle, and Coronary Artery Disease Amit Khera, MD, Massachusetts General Hospital
12:45–1:45 Speaker luncheon
1:45–2:15 Mediterranean diet, olive oil and HDL functionality in the PREDIMED trial Montse Fitó, PhD, IMIM, (Barcelona, Spain)
2:15–2:45 Effects of polyphenol intake on cardiovascular risk markers Rosa M Lamuela-Raventós, PhD, University of Barcelona, (Barcelona, Spain)
2:45–3:15 Novel findings in metabolomics in the PREDIMED Study Miguel A. Martínez-González, MD, PhD, MPH, Univ. Navarra, (Pamplona, Spain)
3:15–3:45 Coffee break
3:45–4:15 Integrative Genomics in the Framingham Heart Study Daniel Levy, MD, PhD, NHLBI
4:15–4:45 New advances in gut microbiota and health outcomes Curtis Hutternhower, PhD, MS, Harvard TH Chan School of Public Health
4:45–5:00 Day 1 closing remarks
Wednesday, May 31, 2017
HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH, BOSTON, MA Omics: Advances, Applications, and Translation in Nutrition and Epidemiology- 3rd ANNUAL SYMPOSIUM
8:30–8:45 Welcome, overview of second day program Frank Hu, MD, PhD, Harvard T.H. Chan School of Public Health
8:45–9:30 Overview/Summary of current status of CVD and T2D metabolomics projects in the PREDIMED Miguel A. Martínez-González, MD, PhD, MPH, Univ. Navarra (Pamplona, Spain)
9:30–10:00 Latest findings of PREDIMED and PREDIMED PLUS Jordi Salas-Salvadó, MD, PhD, Universitat Rovira i Virgili (Reus, Spain) 10:00–10:30 Methods on metabolic profiling on CVD and T2D projects / other new studies Clary Clish, PhD, The Broad Institute of MIT and Harvard
10:30–10:50 Coffee break
10:50–11:20 BCAA and T2D in the PREDIMED Study / preliminary data of the T2D metabolomics project Miguel Ruiz-Canela, PhD, Universidad de Navarra
11:20–11:40 Lipidomics and CVD / Preliminary data of the T2D project Estefanía Toledo, PhD, Universidad de Navarra (Pamplona, Spain) 11.40–12:00 Lipidomics (PCA analysis and scores) Cristina Razquin, PhD, Universidad of Navarra (Pamplona, Spain)
12:00–1:00 Speaker luncheon
1:00–1:30 Lipid network analysis/ Bile acids and CVD Daniel Wang, MD, Harvard T.H. Chan School of Public Health
1:30–1:50 Untargeted metabolomics in the PREDIMED Yan Zheng, PhD, Harvard T.H. Chan School of Public Health
1:50–2:20 Choline and proline pathways and CVD / Acylcarnitines and T2D in T2D metabolomics project Marta Guasch-Ferré, MD PhD, Harvard T.H. Chan School of Public Health
2:20–2:40 Tryptophan/urea cycle metabolites Edward Yu, Harvard T.H. Chan School of Public Health
2:40–3:00 Coffee break
3:00–3:30 Methods to analyze metabolomics data and novel statistical approaches. Metabolomic footprints of the 14-point PREDIMED MedDiet score Liming Liang, Harvard T.H. Chan School of Public Health
3:30–3:50 Metabolomic footprints of the Mediterranean diet: the effect of the randomized PREDIMED intervention Cristina Razquin, PhD, Universidad of Navarra (Pamplona, Spain)
3:50–4:10 Metabolite predictors of food groups Mònica Bullo, PhD, Universitat Rovira i Virgili (alternatively, Christopher Papandreou) (Reus, Spain)
4:10–4:50 Competing renewal of the T2D grant Miguel A. Martínez-González / Frank Hu
4:50–5:00 Conference closing remarks Frank Hu, MD, PhD, Harvard T.H. Chan School of Public Health
9:00–9:15 Overview of program, introduction to systems epidemiology Frank Hu, MD, PhD, Chair, Dpt. Nutrition, Harvard T.H. Chan School of Public Health
9:15–9:45 Novel findings in genomics/metabolomics in the ARIC Study Eric Boerwinkle, PhD, Baylor College of Medicine, Houston
9:45–10:15 The Women’s Genome Health Study (WGHS): Recent progress and opportunities in the genetic epidemiology of aging Daniel Chasman, MD, PhD, Brigham and Women’s Hospital
10:15–10:45 Precision nutrition for obesity management based on omics J Alfredo Martínez, MD PhD, Universidad de Navarra (Pamplona, Spain)
10:45–11:15 Coffee break
11:15–11:45 Genetic variation on T2D traits James B Meigs, MD, PhD, Massachusetts General Hospital
11:45–12:15 Metabolomics and other omics of diabetes Thomas J Wang, PhD, Vanderbilt University Medical Center
12:15–12:45 Genes, Lifestyle, and Coronary Artery Disease Amit Khera, MD, Massachusetts General Hospital
12:45–1:45 Speaker luncheon
1:45–2:15 Mediterranean diet, olive oil and HDL functionality in the PREDIMED trial Montse Fitó, PhD, IMIM, (Barcelona, Spain)
2:15–2:45 Effects of polyphenol intake on cardiovascular risk markers Rosa M Lamuela-Raventós, PhD, University of Barcelona, (Barcelona, Spain)
2:45–3:15 Novel findings in metabolomics in the PREDIMED Study Miguel A. Martínez-González, MD, PhD, MPH, Univ. Navarra, (Pamplona, Spain)
3:15–3:45 Coffee break
3:45–4:15 Integrative Genomics in the Framingham Heart Study Daniel Levy, MD, PhD, NHLBI
4:15–4:45 New advances in gut microbiota and health outcomes Curtis Hutternhower, PhD, MS, Harvard TH Chan School of Public Health
4:45–5:00 Day 1 closing remarks
Wednesday, May 31, 2017
HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH, BOSTON, MA Omics: Advances, Applications, and Translation in Nutrition and Epidemiology- 3rd ANNUAL SYMPOSIUM
8:30–8:45 Welcome, overview of second day program Frank Hu, MD, PhD, Harvard T.H. Chan School of Public Health
8:45–9:30 Overview/Summary of current status of CVD and T2D metabolomics projects in the PREDIMED Miguel A. Martínez-González, MD, PhD, MPH, Univ. Navarra (Pamplona, Spain)
9:30–10:00 Latest findings of PREDIMED and PREDIMED PLUS Jordi Salas-Salvadó, MD, PhD, Universitat Rovira i Virgili (Reus, Spain) 10:00–10:30 Methods on metabolic profiling on CVD and T2D projects / other new studies Clary Clish, PhD, The Broad Institute of MIT and Harvard
10:30–10:50 Coffee break
10:50–11:20 BCAA and T2D in the PREDIMED Study / preliminary data of the T2D metabolomics project Miguel Ruiz-Canela, PhD, Universidad de Navarra
11:20–11:40 Lipidomics and CVD / Preliminary data of the T2D project Estefanía Toledo, PhD, Universidad de Navarra (Pamplona, Spain) 11.40–12:00 Lipidomics (PCA analysis and scores) Cristina Razquin, PhD, Universidad of Navarra (Pamplona, Spain)
12:00–1:00 Speaker luncheon
1:00–1:30 Lipid network analysis/ Bile acids and CVD Daniel Wang, MD, Harvard T.H. Chan School of Public Health
1:30–1:50 Untargeted metabolomics in the PREDIMED Yan Zheng, PhD, Harvard T.H. Chan School of Public Health
1:50–2:20 Choline and proline pathways and CVD / Acylcarnitines and T2D in T2D metabolomics project Marta Guasch-Ferré, MD PhD, Harvard T.H. Chan School of Public Health
2:20–2:40 Tryptophan/urea cycle metabolites Edward Yu, Harvard T.H. Chan School of Public Health
2:40–3:00 Coffee break
3:00–3:30 Methods to analyze metabolomics data and novel statistical approaches. Metabolomic footprints of the 14-point PREDIMED MedDiet score Liming Liang, Harvard T.H. Chan School of Public Health
3:30–3:50 Metabolomic footprints of the Mediterranean diet: the effect of the randomized PREDIMED intervention Cristina Razquin, PhD, Universidad of Navarra (Pamplona, Spain)
3:50–4:10 Metabolite predictors of food groups Mònica Bullo, PhD, Universitat Rovira i Virgili (alternatively, Christopher Papandreou) (Reus, Spain)
4:10–4:50 Competing renewal of the T2D grant Miguel A. Martínez-González / Frank Hu
4:50–5:00 Conference closing remarks Frank Hu, MD, PhD, Harvard T.H. Chan School of Public Health
